Other

2028

Abbott 2028 decreased by 75.9% to $700.00M in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), 2028 shows a downward trend with a -14.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2022
Last reportedQ4 2025Feb 20, 2026

How to read this metric

A predictable and manageable maturity schedule indicates strong financial planning and lower risk of default.

Detailed definition

This represents the specific portion of long-term debt principal scheduled for repayment during the 2028 fiscal year. It...

Peer comparison

Most large-cap industrial companies maintain a balanced maturity schedule to avoid concentrated repayment pressure.

Metric ID: other_long_term_debt_maturities_repayments_of_principal__62d406

Historical Data

4 periods
 Q4 '22Q4 '23Q4 '24Q4 '25
Value$1.10B$1.50B$2.90B$700.00M
QoQ Change+36.4%+93.3%-75.9%
YoY Change+36.4%+93.3%-75.9%
Range$700.00M$2.90B
Avg YoY Growth+17.9%
Median YoY Growth+36.4%

Frequently Asked Questions

What is Abbott's 2028?
Abbott (ABT) reported 2028 of $700.00M in Q4 2025.
What is the long-term trend for Abbott's 2028?
Over 3 years (2022 to 2025), Abbott's 2028 has grown at a -14.0% compound annual growth rate (CAGR), from $1.10B to $700.00M.
What does 2028 mean?
The amount of long-term debt principal that must be repaid in 2028.